|
|
|
|
| LEADER |
00000cam a22000004a 4500 |
| 001 |
6737539 |
| 003 |
ICU |
| 005 |
20090730133800.0 |
| 008 |
070123m20089999ne a b 001 0 eng |
| 010 |
|
|
|a 2007002969
|
| 020 |
|
|
|a 9780123742124 (set of v. 1 & v. 2)
|
| 020 |
|
|
|a 0123742129 (set of v. 1 & v. 2)
|
| 020 |
|
|
|a 9780123704689 (v. 1 : hardcover : alk. paper)
|
| 020 |
|
|
|a 0123704685 (v. 1 : hardcover : alk. paper)
|
| 020 |
|
|
|a 9780123741837 (v. 2 : hardcover : alk. paper)
|
| 020 |
|
|
|a 0123741831 (v. 2 : hardcover : alk. paper)
|
| 035 |
|
|
|a 2007002969
|
| 035 |
|
|
|a (OCoLC)81252647
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d YDX
|d NLM
|d BTCTA
|d BAKER
|d YDXCP
|d VAM
|d UtOrBLW
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RC280.L8
|b C34 2008
|
| 060 |
0 |
0 |
|a QZ 241
|b C2144 2008
|
| 082 |
0 |
4 |
|a 616.99/40754
|2 22
|
| 082 |
0 |
0 |
|a 616.99/4240754
|2 22
|
| 245 |
0 |
0 |
|a Cancer imaging /
|c edited by M.A. Hayat.
|
| 260 |
|
|
|a Amsterdam ;
|a Boston :
|b Elsevier, Academic Press,
|c c2008-
|
| 300 |
|
|
|a v. :
|b ill. (some col.) ;
|c 29 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 440 |
|
0 |
|a Cancer imaging
|
| 504 |
|
|
|a Includes bibliographical references and indexes.
|
| 505 |
0 |
|
|a V. 1: Strategies for imaging biology in cancer and other diseases -- Synthesis of ¹⁸F-fluoromisonidazole tracer for positron emission tomography -- Radiation hormesis -- Molecular imaging in early therapy monitoring -- Positron emission tomography in medicine: an overview -- Radiation dose and image quality -- Contrast agents for magnetic resonance imaging: an overview -- Whole-body computed tomography screening -- Whole-body ¹⁸F-fluorodeoxyglucose-positron emission tomography: is it valuable for health screening? -- Staging solid tumors with ¹⁸F-fluorodexoyglucose-positron emission tomography/computed tomography -- Laser doppler perfusion imaging: clinical diagnosis -- Dynamic sonographic tissue perfusion measurement with the pixelflux method -- Immuno-positron emission tomography -- Role of imaging biomarkers in drug development -- The role of imaging in lung cancer -- Lung cancer staging: integrated ¹⁸F-fluorodeoxyglucose-positron emission tomography/computed tomography and computed tomography alone -- Computed tomography screening for lung cancer -- Lung cancer: role of multislice computed tomography -- Surgically resected pleomorphic lung carcinoma: computed tomography -- Lung cancer: low dose helical computed tomography -- Lung cancer: computer-aided diagnosis with computed tomography -- Stereotactic radiotherapy for non-small lung carcinoma computed tomography -- Thin-section computed tomography correlates with clinical outcome in patients with mucin-producing adenocarcinoma of the lung -- Non-small lung carcinoma: ¹⁸F-fluorodeoxyglucose-positron emission tomography -- Evaluating positron emission tomography in non-small cell lung cancer: moving beyond accuracy to outcome -- Non-small cell lung cancer: false-positive results with ¹⁸F-fluorodeoxyglucose-positron emission tomography -- Oxygen-enhanced proton magnetic resonance imaging of the human lung -- Detection of pulmonary gene transfer using iodide-124/positron emisson tomography -- Lung cancer with idiopathic pulmonary fibrosis: high-resolution computed tomography -- Categorization of mammographic density for breast cancer: clinical significance -- Breast tumor classification and visualization with machine-learning approaches -- Mass detection scheme for digitized mammography -- Full-field digital phase-contrast mammography -- Full-field digital mammography versus film-screen mammography -- Use of contrast-enhanced magnetic resonance imaging for detecting invasive lobular carcinoma --
|
| 505 |
0 |
|
|a Axillary lymph node status in breast cancer: pinhole collimator single-photon emission computed tomography -- Detection of small-size primary breast cancer: ⁹⁹mTc-tetrofosmin single photon emission computed tomography -- Microcalcification in breast lesion: radiography and histopathology -- Benign and malignant breast lesions: doppler sonograpy -- Response to neoadjuvant treatment in patients with locally advanced brest cancer: color-doppler ultrasound contrast medium (levovist) -- Magnetic resonance spectroscopy of breast cancer: current techniques and clinical applications -- Breast scintigraphy -- Primary breast cancer: false-negative and false-positive bone scintigraphy -- Improved sensitivity and specificity of breast cancer thermography -- Optical mammography -- Digital mammography -- Screening for breast cancer in women with a familial or genetic predisposition: magnetic resonance imaging versus mammography -- Mammographic screening: impact on survival -- False-positive mammography examinations -- Breast dose in thoracic computed tomography -- Absorbed dose measurement in mammography -- Metastatic choriocarcinoma to the breast: mammography and color doppler ultrasound -- Detection and characterization of breast lesions: color-coded signal intensity curve software for magnetic resonance-based breast imaging -- Detection of breast malignancy: different magnetic resonance imaging modalities -- Breast lesions: computerized analysis of magnetic resonance imaging -- Optical imaging techniques for breast cancer -- Magnetic resonance imaging: measurements of breast tumor volume and vascularity for monitoring response to treatment -- Defining advanced breast cancer: ¹⁸F-fluorodeoxyglucose-positron emission tomography -- Leiomyoma of the breast parenchyma: mammographic, sonographic, and histopathologic features -- Detection of breast cancer: dynamic infrared imaging -- Phyllodes breast tumors: magnetic resonance imaging.
|
| 505 |
0 |
|
|a V. 2: Proton computed tomography -- Multidetector computed tomography -- Megavoltage computed tomography imaging -- Integrated set-3000G/X positron emission tomography scanner -- High-resolution magic angle spinning magnetic resonance spectroscopy -- Spatial dependency of noise and its correlation among various imaging modalities -- Computed tomography scan methods account for respiratory motion in lung cancer -- Respiratory motion artifact using positron emission tomography/computed tomography -- Gadolinium-based contrast media used in magnetic resonance imaging: an overview -- Molecular imaging of cancer with superparamagnetic iron-oxide nanoparticles -- Adverse reactions to iodinated contrast media -- The accuracy of diagnostic radiology -- Diffraction-enhanced imaging: applications to medicine -- Role of imaging in drug development -- Characterization of multiple aspects of tumor physiology by multitracer positron emission tomography -- Whole-body magnetic resonance imaging in patients with metastases -- Whole-body imaging in oncology: positron emission tomography/computed tomography (PET/CT) -- Whole-body cancer imaging: simple image fusion with positron emission tomography/computed tomography -- Whole body tumor imaging: O-[¹¹C]methyl-L-tyrosine/positron emission tomography -- Tumor proliferation 2-[¹¹C]-thymidine positron emission tomography -- ¹⁸F-fluorodeoxyglucose-positron emission tomography in oncology: advantages and limitations -- Positron emission tomography imaging of tumor hypoxia and angiogenesis: imaging biology and guiding therapy -- Noninvasive determination of angiogenesis: molecular targets and tracer development -- Gross tumor volume and clinical target volume: anatomical computed tomography and functional FDG-PET -- Post-treatment changes in tumor microenvironment: dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging -- In vivo molecular imaging in oncology: principles of reporter gene expression imaging -- Medical radiation-induced cancer -- Adrenal lesions: role of computed tomography, magnetic resonance imaging, ¹⁸F-fluorodeoxyglucose-positron emission tomography, and positron emission tomography/computed tomography -- Hemangioendothelioma: whole-body technetium-99m red blood cell imaging-magnetic resonance imaging -- Malignant bone involvement: assessment using positron emission tomography/computed tomography -- Bone metastasis: single photon emission computed tomography/computed tomography -- Bone cancer: comparison of ¹⁸F-fluorodeoxyglucose-positron emission tomography with single photon emission computed tomography -- Bone metastasis in endemic nasopharyngeal carcinoma: ¹⁸F-fluorodeoxyglucose-positron emission tomography -- Colorectal polyps: magnetic resonance colonography -- Early bile duct carcinoma: ultrasound, computed tomography, cholangiography, and magnetic resonance cholangiography -- Incidental extracolonic lesions: computed tomography -- Colorectal cancer: magnetic resonance imaging-cellular and molecular imaging --
|
| 505 |
0 |
|
|a Potential new staging perspectives in colorectal cancer: whole-body PET/CT-colonography -- Thoracic esophageal cancer: interstitial magnetic lymphography using superparamagnetic iron -- Esophageal cancer; comparsion of ¹⁸F-fluoro-3deoxy-3-[L]-fluorothymidine-positron emission tomography with ¹⁸f-fluorodeoxyglucose-positron emission tomography -- Gastrointestinal stromal tumors: positron emission tomography and contrast-enhanced helical computed tomography -- Gastrointestinal stromal tumor: computed tomography -- Gastrointestinal lipomas: computed tomography -- Computed tomography in peritoneal surface malignancy -- Gastrointestinal tumors: computed tomography/endoscopic ultrasonography -- Magnetic resonance cholangiopancreatography -- Occult primary head and neck carcinoma: role of positron emission tomography imaging -- Benign and malignant nodes in the neck: magnetic resonance microimaging -- Oral squamous cell carcinoma: comparison of computed tomography with magnetic resonance imaging -- Computed tomography in renal cell carcinoma -- Renal cell carcinoma subtypes: multislice computed tomography -- Renal impairment: comparison of noncontrast computed tomography, magnetic resonance urography, and combined abdominal radiography/ultrasonography -- Renal lesions: magnetic resonance diffusion-weighted imaging -- Malignant lymphoma: ¹⁸F-fluorodeoxyglucose-positron emission tomography -- Malignant melanoma: positron emission tomography -- Multiple myeloma: scintigraphy using technetium-99m-2-methoxyisobutylisonitrile -- Nasopharyngeal carcinoma: ¹⁸F-fluorodexyglucose-positron emission tomography -- Nasopharyngeal carcinoma for staging and restaging with ¹⁸F-FDG-PET/CT -- Ovarian sex cord stromal tumors: computed tomography and magnetic resonance imaging -- Malignant germ cell tumors: computed tomography and magnetic resonance imaging -- Ovarian small round cell tumors: magnetic resonance imaging -- Ovarian borderline serous surface papillary tumor: magnetic resonance imaging -- Chronic pancreatics versus pancreatic cancer: positron emission tomography -- Pancreatic cancer: P-[¹²³l] lodo-L-phenylalanine single photon emission tomography for tumor imaging -- Pancreatic islet cell tumors: endoscopic ultrasonography -- Parotid gland tumors: advanced imaging technologies -- Pituitary macroadenomas: intraoperative magnetic resonance imaging and endonasal endoscopy -- Penile cancer staging: ¹⁸F-fluorodeoxyglucose-positron emission tomography/computed tomography -- Malignant peripheral nerve sheath tumors: [¹⁸F]fluorodeoxyglucose-positron emission tomography -- Prostate cancer: ¹¹C-choline-positron emission tomography -- Metabolic characterization of prostate cancer: magnetic resonance spectroscopy -- Prostate cancer: diffusion-weighted imaging -- Prostatic secretory protein of 94 amino acids, gene-directed transgenic prostate cancer: three-dimensional ultrasound microimaging -- Prostate cancer within the transition zone: gadolinium-enhanced magnetic resonance imaging -- Rectal wall invasion of locally advanced prostate cancer: comparison of magnetic resonance imaging with transrectal ultrasound -- Local staging of prostate cancer using endorectal coil magnetic resonance imaging -- Extremity sarcoma: positron emission tomography -- Retroperitoneal synovial sarcoma: color-doppler ultrasound, computed tomography, and magnetic resonance imaging -- Thymona: computed tomography -- Hemolymphangiomatosis of the spleen: conventional diagnostic imaging and magnetic resonance imaging with superparamagnetic contrast agent -- Thyroid cancer: ¹⁸F-FDG-positron emission tomography -- Thyroid cancer: ¹⁸F-fluoro-2-deoxy-D-glucose-positron emission tomography (an overview) -- Diagnosis of thyroid cancer in children: value of power doppler ultrasound.
|
| 650 |
|
0 |
|a Cancer
|x Imaging.
|0 http://id.loc.gov/authorities/subjects/sh89006835
|
| 650 |
1 |
2 |
|a Diagnostic Imaging
|x methods.
|
| 650 |
1 |
2 |
|a Neoplasms
|x diagnosis.
|
| 650 |
2 |
2 |
|a Breast Neoplasms
|x diagnosis.
|
| 650 |
2 |
2 |
|a Diagnostic Imaging
|x instrumentation.
|
| 650 |
2 |
2 |
|a Lung Neoplasms
|x diagnosis.
|
| 650 |
|
7 |
|a Cancer
|x Imaging.
|2 fast
|0 http://id.worldcat.org/fast/fst00845381
|
| 700 |
1 |
|
|a Hayat, M. A.,
|d 1940-
|0 http://id.loc.gov/authorities/names/n79145304
|1 http://viaf.org/viaf/60369126
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i b33f43c5-7803-5178-8aef-d23312320521
|s 801a9f75-3f58-5904-94ae-bdb7aa4b2fe9
|
| 928 |
|
|
|t Library of Congress classification
|a RC280.L8 C34 2008
|l JCL
|c JCL-Sci
|i 636764
|
| 927 |
|
|
|t Library of Congress classification
|a RC280.L8 C34 2008
|v v.1
|l JCL
|c JCL-Sci
|e VAND
|e CRERAR
|b 80677112
|i 8342086
|
| 927 |
|
|
|t Library of Congress classification
|a RC280.L8 C34 2008
|v v.2
|l JCL
|c JCL-Sci
|e VAND
|e CRERAR
|b 80677174
|i 8342087
|
